FLANAGAN ROBERT J
Insider CIK 1251512 · WPC Director · SGNT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| WPC W. P. Carey Inc. | A Award | 2026-07-01 | 2026-07-02 | 2,824 | — | $0 | 22,756 | SEC↗ |
| WPC W. P. Carey Inc. | A Award | 2025-07-01 | 2025-07-02 | 2,778 | — | $0 | 19,638 | SEC↗ |
| WPC W. P. Carey Inc. | A Award | 2024-07-01 | 2024-07-01 | 3,203 | — | $0 | 16,713 | SEC↗ |
| WPC W. P. Carey Inc. | A Award | 2023-07-03 | 2023-07-05 | 2,553 | — | $0 | 13,510 | SEC↗ |
| WPC W. P. Carey Inc. | A Award | 2022-07-01 | 2022-07-06 | 1,919 | — | $0 | 10,957 | SEC↗ |
| WPC W. P. Carey Inc. | A Award | 2021-07-01 | 2021-07-06 | 2,141 | — | $0 | 9,038 | SEC↗ |
| WPC W. P. Carey Inc. | A Award | 2020-07-01 | 2020-07-06 | 2,180 | — | $0 | 6,897 | SEC↗ |
| WPC W. P. Carey Inc. | P Buy | 2020-03-03 | 2020-03-05 | 1,000 | $82.29 | $82.3K | 4,717 | SEC↗ |
| WPC W. P. Carey Inc. | A Award | 2019-07-01 | 2019-07-02 | 1,867 | — | $0 | 3,717 | SEC↗ |
| WPC W. P. Carey Inc. | A Award | 2018-07-02 | 2018-07-03 | 1,523 | — | $0 | 1,850 | SEC↗ |
| WPC W. P. Carey Inc. | A Award | 2018-04-02 | 2018-04-03 | 327 | — | $0 | 327 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 760 | $21.75 | $16.5K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 1,860 | $21.75 | $40.5K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 5,103 | $10.15 | $51.8K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 1,381 | $21.75 | $30.0K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 8,556 | $21.75 | $186.1K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 691 | $21.75 | $15.0K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | U Tender | 2016-08-29 | 2016-08-31 | 8,050 | $21.75 | $175.1K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | U Tender | 2016-08-29 | 2016-08-31 | 2,000 | $21.75 | $43.5K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | U Tender | 2016-08-29 | 2016-08-31 | 433,770 | $21.75 | $9.43M | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | G Gift | 2016-08-16 | 2016-08-31 | 4,150 | — | $0 | 8,050 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2016-02-25 | 2016-02-25 | 460 | — | $0 | 1,381 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2016-02-25 | 2016-02-25 | 230 | — | $0 | 691 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2016-02-25 | 2016-02-25 | 230 | — | $0 | 12,200 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2016-02-25 | 2016-02-25 | 460 | — | $0 | 11,970 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2016-02-22 | 2016-02-23 | 8,556 | — | $0 | 8,556 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2016-02-22 | 2016-02-23 | 567 | — | $0 | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2016-02-22 | 2016-02-23 | 567 | — | $0 | 11,510 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2016-02-21 | 2016-02-23 | 760 | — | $0 | 760 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2016-02-21 | 2016-02-23 | 760 | — | $0 | 10,943 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2016-02-18 | 2016-02-22 | 930 | — | $0 | 1,860 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2016-02-18 | 2016-02-22 | 930 | — | $0 | 10,183 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2015-04-09 | 2015-04-13 | 921 | — | $0 | 921 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2015-02-25 | 2015-02-27 | 1,841 | — | $0 | 1,841 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2015-02-22 | 2015-02-24 | 567 | — | $0 | 567 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2015-02-22 | 2015-02-24 | 567 | — | $0 | 9,253 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2015-02-21 | 2015-02-24 | 760 | — | $0 | 1,520 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2015-02-21 | 2015-02-24 | 760 | — | $0 | 8,686 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2015-02-18 | 2015-02-20 | 930 | — | $0 | 2,790 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2015-02-18 | 2015-02-20 | 930 | — | $0 | 7,926 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-10-22 | 2014-10-23 | 8,000 | $31.99 | $255.9K | 433,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-10-08 | 2014-10-08 | 8,000 | $31.96 | $255.7K | 441,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-10-07 | 2014-10-08 | 8,000 | $31.15 | $249.2K | 449,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-09-25 | 2014-09-25 | 8,000 | $29.72 | $237.8K | 457,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-09-24 | 2014-09-25 | 8,000 | $30.30 | $242.4K | 465,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-09-12 | 2014-09-12 | 8,000 | $28.25 | $226.0K | 473,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-09-11 | 2014-09-12 | 8,000 | $28.35 | $226.8K | 481,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-08-28 | 2014-08-29 | 8,000 | $27.07 | $216.6K | 489,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-08-27 | 2014-08-29 | 8,000 | $27.30 | $218.4K | 497,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-08-12 | 2014-08-13 | 8,000 | $24.39 | $195.1K | 505,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-08-11 | 2014-08-13 | 8,000 | $24.39 | $195.1K | 513,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-07-31 | 2014-07-31 | 8,000 | $25.20 | $201.6K | 521,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-07-30 | 2014-07-31 | 8,000 | $26.00 | $208.0K | 529,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-07-18 | 2014-07-21 | 8,000 | $26.11 | $208.9K | 537,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-07-17 | 2014-07-21 | 8,000 | $26.25 | $210.0K | 545,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-07-02 | 2014-07-02 | 8,000 | $26.70 | $213.6K | 553,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-07-01 | 2014-07-02 | 8,000 | $26.31 | $210.5K | 561,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-06-18 | 2014-06-18 | 8,000 | $23.26 | $186.1K | 569,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-06-17 | 2014-06-18 | 8,000 | $23.47 | $187.8K | 577,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-06-04 | 2014-06-04 | 8,000 | $22.29 | $178.3K | 585,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-06-03 | 2014-06-04 | 8,000 | $22.05 | $176.4K | 593,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-05-22 | 2014-05-23 | 8,000 | $22.02 | $176.2K | 601,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2014-02-22 | 2014-02-24 | 567 | — | $0 | 1,134 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2014-02-22 | 2014-02-24 | 567 | — | $0 | 6,996 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2014-02-21 | 2014-02-24 | 759 | — | $0 | 2,280 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2014-02-21 | 2014-02-24 | 759 | — | $0 | 6,429 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2014-02-18 | 2014-02-19 | 3,720 | — | $0 | 3,720 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2013-09-16 | 2013-09-18 | 500,000 | $20.03 | $10.02M | 609,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2013-05-13 | 2013-05-13 | 1,276 | — | $0 | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2013-05-13 | 2013-05-13 | 1,276 | $4.23 | $5.4K | 5,670 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2013-02-22 | 2013-02-25 | 567 | — | $0 | 1,701 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2013-02-22 | 2013-02-25 | 567 | — | $0 | 4,394 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2013-02-21 | 2013-02-25 | 3,039 | — | $0 | 3,039 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2012-05-14 | 2012-05-14 | 1,275 | — | $0 | 1,276 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2012-05-14 | 2012-05-14 | 1,275 | $4.23 | $5.4K | 3,827 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2012-02-22 | 2012-02-24 | 2,268 | — | $0 | 2,268 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | G Gift | 2011-12-16 | 2012-04-19 | 1,000 | — | $0 | 2,000 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2011-05-14 | 2012-04-19 | 1,277 | — | $0 | 2,551 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2011-05-14 | 2012-04-19 | 1,277 | $4.23 | $5.4K | 2,552 | SEC↗ |